Recent evidence supports that alterations in hepatocyte-derived exosomes (HDE) may play a role in the pathogenesis of drug-induced liver injury (DILI). HDE-based biomarkers also hold promise to improve the sensitivity of existing in vitro assays for predicting DILI liability. Primary human hepatocytes (PHH) provide a physiologically relevant in vitro model to explore the mechanistic and biomarker potential of HDE in DILI. However, optimal methods to study exosomes in this culture system have not been defined. Here we use HepG2 and HepaRG cells along with PHH to optimize methods for in vitro HDE research. We compared the quantity and purity of HDE enriched from HepG2 cell culture medium by 3 widely used methods: ultracentrifugation (UC), OptiPrep density gradient ultracentrifugation (ODG), and ExoQuick (EQ)-a commercially available exosome precipitation reagent. Although EQ resulted in the highest number of particles, UC resulted in more exosomes as indicated by the relative abundance of exosomal CD63 to cellular prohibitin-1 as well as the comparative absence of contaminating extravesicular material. To determine culture conditions that best supported exosome release, we also assessed the effect of Matrigel matrix overlay at concentrations ranging from 0 to 0.25 mg/ml in HepaRG cells and compared exosome release from fresh and cryopreserved PHH from same donor. Sandwich culture did not impair exosome release, and freshly prepared PHH yielded a higher number of HDE overall. Taken together, our data support the use of UCbased enrichment from fresh preparations of sandwich-cultured PHH for future studies of HDE in DILI.
Hepatotoxicants induce alterations in hepatocyte-derived exosomes (HDE) prior to and in the absence of overt necrosis, supporting a role for HDE in the pathogenesis of drug-induced liver injury (DILI) (Holman et al., 2016; Momen-Heravi et al., 2015a; . Because HDE contain liver-specific mRNAs (Royo et al., 2013) , microRNAs (miRNAs) (Holman et al., 2016; Momen-Heravi et al., 2015b) , and proteins (Conde-Vancells et al., 2008 , they may have value as more sensitive, specific, and mechanistic biomarkers of DILI. HDE-based biomarkers also hold promise to improve the sensitivity of existing in vitro assays for predicting idiosyncratic DILI (IDILI) liability. Overt toxicity from IDILI drugs has proven challenging to recapitulate in vitro as it is thought to require individual susceptibility alleles and an adaptive immune attack on the liver (Usui and Naisbitt, 2017) . However, the early events in the pathogenesis of IDILI, including the release of exosomal danger signals, may be more ubiquitous and therefore suitably measured with cultures of primary human hepatocytes (PHH) from random donors (Mosedale and Watkins, 2017) . Recent work from our group demonstrating an increased release of exosomal microRNA-122 in PHH treated with the IDILI drug tolvaptan supports the use of this approach. In the case of HDE analysis, the use of monocultured hepatocytes over more complex in vitro or in vivo systems also allows for the measurement of both hepatocyte-derived and nonhepatocyte specific exosome content, without the need to selectively enrich HDE over exosomes from other cell types. Therefore, the objective of this study was to identify the best methods for studying HDE from cultured PHH in order to explore their mechanistic and biomarker potential in DILI.
Optimal methods for exosome enrichment greatly depend on the source and the intended use of the vesicles (Witwer et al., 2013) . To our knowledge, this has not been evaluated for HDE. Therefore, we sought to determine the enrichment method that would yield the highest quantity and purity of exosomes from cultured PHH for the purpose of studying HDE as it relates to DILI. Current exosome enrichment methods include approaches based on differential centrifugation, polymer precipitation, sizeexclusion, immunoaffinity capture, and microfluidics (Li et al., 2017; Liga et al., 2015; Momen-Heravi et al., 2013) . We chose to compare the 3 most well-established enrichment methods: ultracentrifugation (UC), OptiPrep density gradient ultracentrifugation (ODG), and ExoQuick (EQ) (Li et al., 2017) . UC uses centrifugal force to separate and purify particulates based on their size, density, and shape. ODG is a variation of this approach which uses a density gradient medium to separate particulates into zones which can be fractionated according to their density, often improving the purity of the particles enriched. EQ is a commercially available precipitation-based approach that uses water-excluding polymers to alter the solubility of exosomes, causing the particles to settle out of solution. Particles can then be pelleted by low-speed centrifugation. For our first aim, we chose to optimize conditions for exosome enrichment using the HepG2 human liver carcinoma cell line, because it would allow for sufficient and uniform material to fully characterize HDE from all 3 enrichment approaches. We evaluated the quantity and purity of HDE via nanoparticle tracking, protein, and RNA analyses.
Once the optimized isolation condition was identified using HepG2 cells, the second aim of this study was to translate this method to more physiologically relevant hepatocyte models to further optimize culture conditions for HDE enrichment. First, we investigated whether Matrigel overlay would impact release of HDE as PHH cultured in a sandwich configuration are the gold standard model for DILI research due to the system's metabolic enzyme competence and hepatobiliary transporter function (Swift et al., 2010; Yang et al., 2016) . Conventional PHH cultures cannot maintain their morphology in culture for more than a few days (Hewitt et al., 2007) , therefore we explored this initial question in HepaRG cells, a human hepatic progenitor cell line that maintains a differentiated hepatocyte phenotype in culture with or without overlay. We also examined the impact of cryopreservation on the ability of PHH to form and release exosomes as cryopreserved cells are often preferred due to the convenience of use and characterization that can be performed in advance of a study (Fuller et al., 2013) . To address the role of cryopreservation, we compared HDE release from freshly isolated and corresponding cryopreserved PHH from the same donor. Experiments in HepaRG cells and PHH were performed on culture day 6 to best reflect a commonly used timepoint for transporter and toxicity studies (Swift et al., 2010) .
MATERIALS AND METHODS

Cell Culture
All cells were cultured at 37 C in 5% CO 2 . HepG2 cells (ATCC) were seeded at a density of 2.1 Â 10 6 cells/ml in T-75 flasks and maintained with DMEM medium, supplemented with FBS, glucose, penicillin/streptomycin, GlutaMax, and sodium pyruvate (Life Technologies, Carlsbad, CA), changed every 2-3 days. Medium was changed to serum-free medium (10 ml/flask) 24 h prior to collection to deplete a source of contaminating exosomes and to better mimic medium conditions for PHH, where the use of serum is not recommended (Hewitt et al., 2007) . HepaRG-NS cells (Triangle Research Labs, RTP, NC) were seeded at a density of 0.8 Â 10 6 cells/ml onto 12-well plates and cultured as recommended by the manufacturer (Biopredic International, Saint-Gr egoire, France) with slight variation: 3 days postplating, cells were overlaid with Matrigel Matrix (Corning, New York) at a concentration ranging from 0.1 to 0.25 mg/ml prepared in Williams E medium supplemented with HepaRG-NS Serum-free Induction Medium (Biopredic International). Cells were maintained in 1 ml of medium/well with a daily medium change for 5 days postoverlay and harvested on day 6. PHH from n ¼ 11 donors (Table 1 and  Supplementary Table 1 ) were plated on 6-well collagen coated plates at an average seeding density of 0.9 Â 10 6 cells/ml, and overlaid with Matrigel Matrix at 0.25 mg/ml 1-day postplating. "Fresh" (ie, never frozen) PHH were seeded < 4 h after isolation. "Cryopreserved" PHH were prepared according to vendoroptimized protocols derived from methods that have been described previously in FAOUN (2012), Smith et al. (2012) , and Terry et al. (2010) . Prior to seeding, cryopreserved PHH were thawed in a 37 C water bath, diluted into warm plating medium, and centrifuged at room temperature (approximately 20 C-25 C).
Hepatocytes were maintained in 2 ml medium/well with William's E medium, penicillin-streptomycin, GlutaMax, HEPES, sodium pyruvate (Life Technologies), dexamethasone (Sigma, St. Louis, MO), and ITS (Corning) with a daily medium change and harvested on day 6.
Cell Morphology, Viability, and Functional Endpoints Photomicrographs were captured daily using a Nikon Eclipse TS100 microscope. ATP levels were measured using the CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, WI) as recommended by the manufacturer. Urea production was measured with the Stanbio BUN Liquid Reagent for Diagnostic Set as recommended by the manufacturer. Albumin production was determined by ELISA (Bethyl Laboratories, Montgomery, TX), as directed by the manufacturer. ATP, urea, and albumin assays were measured on a SpectraMax M3 microplate reader (Molecular Devices, San Jose, CA).
Cell Culture Medium Processing and Exosome Enrichment
Cell culture medium processing. Exosome release was evaluated in medium collected from a 24-h period to correspond to the daily medium change required for PHH. Cell culture medium was harvested and processed as previously described in Van Deun et al. (2014) . Four ml of medium from HepG2 and PHH and 1 ml of medium from HepaRG was used as starting material for each enrichment approach and endpoint analyzed. Briefly, medium was centrifuged at 3000 Â g for 15 min at 4 C to remove cell debris. The resulting supernatant was passed through a 0.45 mm cellulose acetate filter by gravity filtration, concentrated with a 10 K Centricon Plus-70 cenrifugal filter (Millipore, Burlington, Massachusetts), and passed through a 0.22 mm cellulose acetate filter by gravity filtration.
Ultracentrifugation. UC was performed as described (Van Deun et al., 2014) . Briefly, processed cell culture medium was centrifuged at 100 000 Â g for 3 h at 4 C using an Optima XL-80 K ultracentrifuge with a SW 41 Ti swinging-bucket rotor (Beckman Coulter, Brea, CA). Supernatant was removed and exosomal pellet resuspended in 1Â PBS (or necessary lysis buffer).
ExoQuick. Processed cell cultured medium was incubated with EQ-TC reagent (System Biosciences, Palo Alto, CA) and treated as recommended by the manufacturer. The exosomal pellet was resuspended in 1Â PBS (or necessary lysis buffer).
OptiPrep density gradient ultracentrifugation. To perform ODG, the OptiPrep reagent (Sigma) was prepared as previously described in Van Deun et al. (2014) with the following variations: Briefly, the gradient was made by layering 2.5 ml of 40%, 2.5 ml of 20%, 2.5 ml of 10%, and 1.5 ml of 5% working solution in an open-top polyallomer ultracentrifuge tube, with 1.0 ml of the cell culture medium layered on top. The tubes were centrifuged as described, using an Optima XL-80 K ultracentrifuge in a SW 41 Ti swinging-bucket rotor. 12 gradient fractions of 0.8 ml were collected, diluted with 1Â PBS, and centrifuged at 100 000 Â g for 3 h. The pelleted exosomes were resuspended in 1Â PBS (or necessary lysis buffer).
Exosomal RNA Isolation and Analysis
Total exosomal RNA was isolated and levels of albumin mRNA and GAPDH mRNA were measured using previously described methods (Holman et al., 2016) . RNA distribution profiling and total RNA concentration was measured using the Agilent TapeStation.
Argonaute 2-Bound RNA Immunoprecipitation Immunoprecipitation of argonaute 2 (AGO2)-bound RNA was performed as previously described in Rivoli et al. (2017) 
RESULTS
EQ Enriches Significantly More Particles Than UC and ODG Conditioned HepG2 cell culture medium was used to enrich for exosomes by UC, ODG, or EQ to evaluate both the quantity and purity of particles enriched by each approach. Initially particles were assessed by NTA. EQ resulted in a significantly higher number of particles (1.16 Â 10 11 6 2.9 Â 10 10 particles/ml) than both ODG (1.00 Â 10 9 6 1.0 Â 10 9 particles/ml, p < .0001) and UC (2.09 Â 10 10 6 1.3 Â 10 10 particles/ml, p < .001; Figure 1A ) . The size of particles enriched by UC and EQ were similar (approximately 100 6 10 nm), whereas the size of particles enriched by ODG were larger in comparison (125 6 15 nm, p < .05; Figure 1B ). Variation in size was not significantly different across enrichment approaches ( Figure 1C) . A representative plot of particle size distribution for each enrichment approach is shown in Supplementary Figure 1 .
Exosomal Marker CD63 Is Highest in UC-Enriched Particles
Particles derived from each enrichment approach were lysed to analyze protein content. Particles from EQ and UC approaches Supplementary Figure 2) . The exosomal protein CD63 was specifically expressed in particles derived from all 3 approaches following immunoblot analysis using 1.4 mg of protein from each isolation (maximum loading possible based on low protein yield from ODG-enriched particles); the cellular protein prohibitin-1 was undetectable at these protein concentrations (Figure 2A ). To confirm specificity, immunoblotting was conducted at higher protein loading (12 mg) using isolations with high protein yields (UC and EQ); CD63 was abundantly expressed in these fractions ( Figure 2B ) and densitometry analysis of CD63 abundance normalized to prohibitin-1 showed that UC had significantly less cellular contamination when compared with EQ (0.71 6 0.1 fold change to UC, p < .05; Figure 2C ).
UC and EQ-Derived Particles Have Similar RNA Quantity and Composition TapeStation analysis was performed to determine the RNA profile and concentration from particles enriched by UC, ODG, or EQ. Representative electropherograms of EQ-and UC-enriched particles show similar profiles containing 2 major peaks: a narrow peak of smaller miRNAs as well as broader peak of larger mRNAs (Supplementary Figure 3A) . The RNA profile from ODGenriched particles has a peak of smaller miRNAs similar to UC and EQ, however does not contain the broader peak of larger RNAs (Supplementary Figure 3A) . Total RNA concentrations were similar for particles enriched by UC and EQ (approximately 450 pM; Supplementary Figure 3B ). The RNA concentration of particles enriched by ODG was much lower (92.5 6 74.7 pM), although not statistically different from UC or EQ (Supplementary Figure 3B) . RT-qPCR was performed to quantify the expression of specific transcripts that are known to be highly expressed in HDE, including the liver-specific mRNA albumin and more ubiquitous GAPDH. Similar levels of both albumin and GAPDH mRNAs were observed with all 3 enrichment methods (Figure 3 ).
Extravesicular miRNA Contamination Is Observed With EQ
Previous studies have indicated that extravesicular, proteinbound miRNA can be nonspecifically precipitated during exosome enrichment (Rivoli et al., 2017) . To isolate this contaminating miRNA, extravesicular AGO2-bound RNA was immunoprecipitated from fractions of enriched particles from UC or EQ preparations using magnetic beads coated with an antiAGO2 antibody. ODG exosomal fractions were excluded from this analysis due to limited material. Magnetic capture of the AGO2-bound RNA and the removal of the supernatant containing enriched particles was used to separate the extravesicular RNA from the enriched particle fraction. Percentage of extravesicular contamination was determined by quantification of the AGO2-bound miRNA relative to total RNA for both enrichment approaches (Figure 4) . EQ precipitated significantly more contaminating extravesicular miRNA (50.5% 6 1.05% of total RNA) compared with UC (12.9% 6 2.06% of total RNA, p < .0001). Based on these collective data, UC was selected as the method for HDE enrichment for optimizing cell culture conditions.
Matrigel Overlay Does Not Prevent the Release of HDE
The impact of gelled collagen overlay on exosome release was examined using HepaRG cells with or without overlay of Matrigel Figure 1 . EQ enriches the highest number of particles. NTA of (A) particle concentration (of starting medium), (B) size (mode), and (C) variation in size (standard deviation of the mode size) of particles enriched from HepG2 culture medium by UC, ODG, and EQ. Data are represented as mean þ SEM (n ¼ 4 replicate enrichments from the same conditioned medium. *p < .05, ***p < .001, and ****p < .0001 indicate the difference between the enrichment methods (Tukey's multiple comparisons test). Densitometry analysis of CD63 in UC and EQ samples. Data are represented as mean þ SEM (n ¼ 3 replicate enrichments from the same conditioned medium).
*p < .05 indicates the difference between UC and EQ (Student's t test).
matrix at concentrations ranging from 0.1 to 0.25 mg/ml. There were no differences in cell morphology, ATP, or albumin production across the different culture conditions (Figs. 5A-C). Exosomes were enriched from conditioned culture medium and analyzed by NTA. There were no significant differences in particle number across different Matrigel concentrations ( Figure 5D ). However, there was a trend toward a decrease in particle size and variation in size with increasing concentrations of Matrigel (Supplementary Figs. 4A and 4B) , with a statistically significant difference in variation of size at 0.25 mg/ml when compared with no overlay (74.2 6 16.2 vs 39.1 6 2.1 nm, p < .05). A representative plot of particle size distribution for each HepaRG culture approach (reflecting profiles similar to those observed for HepG2) is shown in Supplementary Figure 5 . Based on these data, PHH cultured in sandwich configuration with Matrigel overlay was used for further experiments to characterize exosome release from PHH.
More Exosomes Are Released From Fresh PHH
To determine if cryopreservation affects the quantity of exosomes released from PHH, particle release was evaluated in conditioned medium collected from cultures of fresh and donor-matched cryopreserved PHH. Confluent monolayers of healthy hepatocytes were observed in both fresh and cryopreserved preparations throughout the time in culture (Figure 6 and Supplementary Figure 6) . On culture day 6, cells and medium were harvested for biochemical assessment. No consistent trends in ATP, urea, or albumin levels were observed across the fresh and donor-matched cryopreserved preparations from all donors (Figs. 7A-C) . Exosomes were then enriched from conditioned culture medium and analyzed by NTA. Significantly higher particle concentrations were observed in fresh preparations compared with cryopreserved preparations for donor 1 (4.4 Â 10 11 6 1.55 Â 10 11 vs 1.4 Â 10 10 6 1.6 Â 10 9 particles/ml, p < .01) and donor 2 (4.1 Â 10 11 6 6.15 Â 10 10 vs 1.7 Â 10 10 6 5.3 Â 10 9 particles/ml, p < .001; Figure 7D ). No consistent trends in particle size ( Figure 7E ) and variation in size ( Figure 7F ) were observed across the fresh and donor-matched cryopreserved preparations from all donors. A representative plot of particle size distribution for each donor and preparation (reflecting profiles similar to those observed for HepG2 and HepaRG) is shown in Supplementary Figure 7 .
DISCUSSION
The optimal method for exosome enrichment is dependent upon the source and intended use of the exosomes. In this study, we sought to determine the best enrichment method for exosomes from cultured PHH where the quantity and purity of exosomes were the most important considerations. To enable discovery research, we hope to obtain mg-level quantities of HDE protein and RNA for "omics"-based profiling approaches. We are particularly interested in exosomes for DILI research as the packaging of signaling molecules into vesicles appears to support selective targeting to other cell types (Momen-Heravi et al., 2015a), which may be important in the pathogenesis of idiosyncratic reactions. Finally, the focus of our work was HDE released from cultured cells. Currently this is the only way to ensure that the exosomes being studied are in fact hepatocyte-derived. This also supports the use of exosomes for in vitro assays to predict IDILI liability. The development of methods to isolate exosomes from biofluids such as blood using hepatocyte-specific transmembrane proteins and/or a focus on hepatocyte-specific exosomal content may eventually enable HDE to be used as biomarkers in vivo as well. Exosomes, as opposed to larger microvesicles or apoptotic bodies, can readily cross through fenestrations in the sinusoidal endothelium and enter the bloodstream (CondeVancells et al., 2008) . However, conclusions regarding the methods described here are limited to HDE enriched from cell culture medium. Although ODG has been previously shown to yield the most pure population of exosomes (Kalra et al., 2013; Van Deun et al., 2014) , in our study, this approach had to be eliminated from consideration due to the insufficient quantity of the HDE enriched. We did observe that ODG enriched a pure population of vesicles with an RNA profile similar to that previously reported for this enrichment approach (Van Deun et al., 2014) . Interestingly, levels of both albumin and GAPDH mRNA enriched by ODG were comparable to that of UC and EQ, despite the overall lower quantities of particles, protein, and RNA enriched by this method. This suggests that ODG may in fact enrich for a different subpopulation of exosomes with higher levels of select transcripts.
The size of particles enriched by ODG was in the range of 50-150 nm previously reported for exosomes (Szabo and Momen-Heravi, 2017) , although slightly larger than the particles enriched by UC and EQ. However, inadequate amounts of vesicular protein and RNA prevented the assessment of purity using western blotting or immunoprecipitation methods. For our intended use, the insufficient quantity of exosomes yielded by ODG would preclude profiling HDE content, and therefore it was removed from further comparison analyses. Of the other 2 enrichment methods, UC was determined to provide the optimal combination of HDE quantity and purity. We have previously employed EQ to enrich HDE (Holman et al., 2016; , and it may be the preferred method if particle quantity is the only criteria for selection. NTA showed that EQ enriches more particles compared with UC. However, comparisons of total protein and RNA as well as GAPDH and liver-specific albumin mRNA suggest that UC and EQ enrich similar levels of protein and RNA. Additionally, the RNA profiles shown for UC and EQ similarly reflected those of exosomal particles as indicated by the absence of 18S and 28S ribosomal RNA peaks (Crescitelli et al., 2013; Ji et al., 2014) . These discrepancies in characterization may be explained by the detection of nonexosomal particles by NTA. NTA cannot differentiate exosomes from other extracellular vesicles or other contaminating material such as aggregated proteins. Both UC and EQ are known to enrich nonexosomal contaminants, including proteins, RNA, lipids, and polymers (Li et al., 2017; Tauro et al., 2012) . Our characterization of UC-and EQ-derived particle purity provides evidence of greater nonspecific contamination from EQ. Western blotting illustrated that EQ actually enriched significantly less exosomal protein relative to cellular contamination than UC, suggesting that some of the particles detected by NTA were nonexosomal material. Additionally, immunoprecipitation of extravesicular RNA indicated that approximately half of the total RNA measured from EQ was contaminating extravesicular AGO2-bound miRNA, significantly more than that from UC enrichment. Taken together, these data suggest that UC enriched a higher quantity of pure HDE than EQ.
It should be noted that there are several limitations to the experiments performed here to identify the optimal enrichment method. First, we selected just a single exosome marker to characterize exosome purity by western blotting. CD63 is one of the most commonly used markers to evaluate exosome preparations (Lö tvall et al., 2014) ; however, it has been observed in lowspeed centrifugation pellets containing larger vesicles (Kowal et al., 2016) . Second, we chose not to characterize vesicles using electron microscopy as this qualitative endpoint would not allow for quantitative comparison across the different enrichment approaches. However, we have previously verified the presence of circular, membrane-bound vesicles, approximately 100 nm in diameter, in EQ-enriched exosome preparations from human and rat hepatocytes (Holman et al., 2016) . Next, all studies here were performed in untreated cells. Although different drug treatments in a DILI study could impact the performance of different enrichment approaches, our results should correspond to "vehicle-treated" controls, which is arguably the most important condition to optimize. Finally, optimization experiments to select the best approach to enrich exosomes were performed in HepG2 cells, which are phenotypically divergent from PHH. However, the most notable differences (eg, metabolism) are less likely to impact exosome enrichment methods based on particle size and density which appear to translate fairly well across exosomes from multiple cell and organ types. Furthermore, our findings are in line with previous studies in other cell systems that demonstrate the improved purity of centrifugation-based methods (Van Deun et al., 2014) . And we demonstrated comparable NTA profiles for particles enriched by UC from HepG2, HepaRG, and PHH. Although not the focus of this manuscript, our results support the possible use of these additional hepatocyte models for in vitro HDE research.
We also sought to optimize conditions to enable studies of HDE from sandwich-cultured PHH. We observed that Matrigel overlay did not inhibit exosome release from HepaRG cells and in fact, the higher concentrations of Matrigel decreased particle size and variation in size, suggesting that the overlay improves exosome release. It is well known that sandwich culture improves primary hepatocyte viability and function (Sidhu et al., 1993) . This has also been more recently demonstrated in HepaRG cells (Jackson et al., 2016) and is supported by the trend toward increasing albumin production with increasing Matrigel overlay concentration observed in our study. Therefore, it is possible that gelled collagen overlay is also improving hepatocellular functions that preferentially produce and release exosomes over larger extracellular vesicles. However, we cannot rule out that overlay impacts other aspects of particle release not evaluated here (eg, exosome content) and/or that larger vesicles are also interesting in the context of DILI. We are also unable to fully characterize the impact of gelled collagen overlay in PHH as the confounding effects on cell function and viability would preclude a direct comparison. Although we believe the findings in HepaRG cells will extend to PHH, this is another limitation of our study.
A surprising challenge of this study was the difficulty in obtaining cryopreserved PHH from the corresponding freshly prepared donor. Only 3 of the 11 fresh donors used for our studies had corresponding cryopreserved hepatocytes that could be successfully plated and maintained in sandwich culture format (Table 1) . This suggests that there may be donor-specific factors that influence the success of hepatocyte culture after cryopreservation, and demonstrates the benefit of using fresh PHH to evaluate a range of donors in our proposed studies of HDE as it relates to DILI.
Furthermore, we observed that freshly prepared PHH yielded a significantly higher number of HDE than corresponding cryopreserved preparations in 2 of 3 donors. No significant difference was observed in particle release between fresh and cryopreserved preparations of donor 3. However, the fresh preparation of donor 3 had the lowest particle concentration of the 11 donors examined in this study (Supplementary Figure 8) , suggesting that there may have been something unique to the fresh preparation of this donor impacting particle release. Caution should be used in the interpretation of these results as only 3 donors were examined. However, the finding that freshly versus cryopreserved PHH yield a higher number of HDE was statistically significant when values from all 3 donors were pooled (p < .01, Student's t test). Furthermore, this trend was observed consistently over time in culture (Supplementary Figure  9) . Therefore, we believe these findings also support the use of fresh PHH in our future studies which need a high quantity of HDE. Cryopreserved PHH may be useful for other HDE studies; however, future work should be done to explore how the cryopreservation process impacts exosome release.
Taken together, our data suggest that UC-based enrichment from fresh preparations of PHH cultured in sandwich format provide an optimal combination of HDE quantity and purity. Future studies will utilize these methods to explore the mechanistic and biomarker potential of HDE in DILI.
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